DARPA's Living Foundries program awarded $31.8M to MIT for advanced biotechnology R&D over 7 years

Contract Overview

Contract Amount: $31,863,306 ($31.9M)

Contractor: Massachusetts Institute of Technology

Awarding Agency: Department of Defense

Start Date: 2015-05-04

End Date: 2022-03-31

Contract Duration: 2,523 days

Daily Burn Rate: $12.6K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 3

Pricing Type: COST NO FEE

Sector: R&D

Official Description: IGF::OT::IGF LIVING FOUNDRIES: 1000 MOLECULES - TA2. DARPA'S LIVING FOUNDRIES: 1000 MOLECULES PROGRAM SEEKS TO BUILD A SCALABLE, INTEGRATED, RAPID DESIGN AND PROTOTYPING INFRASTRUCTURE FOR THE FACILE ENGINEERING OF BIOLOGY. TECHICAL AREA (TA)1, THE SUBJECT OF THIS CONTRACT, TA2 WILL BUILD OFF OF AND EXECUTE THE IMPROVED TECHNICAL APPROACH AND PLAN GENERATED DURING TA1. TA2 WILL CONSIST OF THREE PHASES AND WILL REQUIRE THE PERFORMER TO DEMONSTRATE THEIR CAPABILITIES TO GENERATE GENETIC DESIGNS AND PLATFORMS WITH INCREASING SOPHISTICATION AND SCALE. PHASE 1 (BASE/CLIN 0001) WILL SERVE AS AN INITIAL PRESSURE TEST REQUIRING THE PERFORMER TO PRODUCE AT LEAST 10 MOLECULES BY THE END OF THE PHASE.

Place of Performance

Location: CAMBRIDGE, MIDDLESEX County, MASSACHUSETTS, 02139

State: Massachusetts Government Spending

Plain-Language Summary

Department of Defense obligated $31.9 million to MASSACHUSETTS INSTITUTE OF TECHNOLOGY for work described as: IGF::OT::IGF LIVING FOUNDRIES: 1000 MOLECULES - TA2. DARPA'S LIVING FOUNDRIES: 1000 MOLECULES PROGRAM SEEKS TO BUILD A SCALABLE, INTEGRATED, RAPID DESIGN AND PROTOTYPING INFRASTRUCTURE FOR THE FACILE ENGINEERING OF BIOLOGY. TECHICAL AREA (TA)1, THE SUBJECT OF THIS CONTRACT, TA2 … Key points: 1. Contract focuses on developing scalable infrastructure for biological engineering. 2. Technical Area 2 builds upon prior research to demonstrate increasing sophistication in genetic design. 3. The contract includes phased deliverables, with an initial pressure test requiring 10 molecule productions. 4. This award represents a significant investment in cutting-edge biotechnology research. 5. The project aims to accelerate the design and prototyping of biological systems. 6. MIT's selection suggests strong confidence in their research capabilities.

Value Assessment

Rating: good

The contract's total value of $31.8M over approximately 7 years (2523 days) for a definitive cost-no-fee contract is within a reasonable range for advanced R&D projects of this complexity. Benchmarking against similar large-scale biotechnology research initiatives funded by agencies like DARPA suggests that the allocated funds are appropriate for the ambitious goals of developing scalable biological engineering infrastructure. The cost-no-fee structure implies that the government is primarily focused on achieving specific research outcomes rather than managing detailed cost expenditures, which is common in high-risk, high-reward R&D.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating that multiple bidders had the opportunity to submit proposals. While the specific number of bidders is not provided, this procurement method generally fosters a competitive environment, allowing the agency to select the most capable offeror based on technical merit and proposed approach. The competitive process is designed to ensure that the government receives the best value for its investment in complex research and development.

Taxpayer Impact: Full and open competition helps ensure that taxpayer funds are used efficiently by driving innovation and potentially lowering costs through a robust bidding process.

Public Impact

The primary beneficiaries are the scientific community and national security interests, through advancements in biotechnology. Services delivered include research and development in biotechnology, specifically focusing on genetic design and biological engineering. The geographic impact is primarily within the research and development sector, with potential for broader applications in various industries. Workforce implications include the potential for highly skilled jobs in biotechnology research and development at MIT and collaborating institutions.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

The long duration of the contract (over 7 years) could present challenges in adapting to rapidly evolving scientific landscapes.
The 'cost-no-fee' structure, while common in R&D, requires careful monitoring to ensure progress aligns with funding.
The complexity of the research may lead to unforeseen technical hurdles and potential delays.
Defining and measuring 'increasing sophistication and scale' across phases requires clear, objective metrics.

Positive Signals

The award to a prestigious institution like MIT signals a high level of confidence in their technical expertise.
The phased approach with clear deliverables allows for iterative development and risk mitigation.
The focus on building scalable infrastructure has the potential for significant long-term impact.
Full and open competition suggests a thorough evaluation process leading to the selection of a highly qualified performer.

Sector Analysis

This contract falls within the Biotechnology Research and Development sector, a rapidly growing field driven by advancements in genomics, synthetic biology, and computational biology. The market for biotechnology R&D is characterized by significant investment from both government and private sectors, aiming to translate scientific discoveries into practical applications. DARPA's Living Foundries program is positioned at the forefront of this innovation, seeking to create foundational capabilities that could revolutionize biological design and manufacturing. Comparable spending benchmarks in advanced R&D, particularly those focused on foundational science with dual-use potential, often involve multi-year, multi-million dollar awards to leading research institutions.

Small Business Impact

This contract does not appear to involve specific small business set-asides, as it was awarded to a large research institution. However, the nature of R&D contracts often involves subcontracting opportunities for specialized services or equipment. It is possible that smaller, innovative firms could be engaged as subcontractors to contribute specific expertise or technologies, thereby indirectly benefiting the small business ecosystem. Further analysis would be needed to determine the extent of any subcontracting plan and its impact on small businesses.

Oversight & Accountability

Oversight for this contract would primarily reside with the Defense Advanced Research Projects Agency (DARPA), a component of the Department of Defense. DARPA is known for its rigorous program management and oversight of high-risk, high-reward research projects. Accountability measures are likely embedded within the phased deliverables and reporting requirements outlined in the contract. Transparency is typically managed through program reviews and the dissemination of research findings, though specific details of ongoing oversight are not publicly detailed.

Related Government Programs

DARPA Biological Technologies Office Programs
National Institutes of Health (NIH) Research Grants
Department of Energy (DOE) Advanced Scientific Computing
National Science Foundation (NSF) Engineering Research Centers

Risk Flags

Long-term project duration may outpace rapid technological advancements in biotechnology.
Complexity of biological systems introduces inherent unpredictability and potential for research setbacks.
Success hinges on the effective integration of diverse computational and experimental methodologies.
Defining and measuring 'increasing sophistication and scale' requires robust, objective metrics.

Frequently Asked Questions

What is this federal contract paying for?

Department of Defense awarded $31.9 million to MASSACHUSETTS INSTITUTE OF TECHNOLOGY. IGF::OT::IGF LIVING FOUNDRIES: 1000 MOLECULES - TA2. DARPA'S LIVING FOUNDRIES: 1000 MOLECULES PROGRAM SEEKS TO BUILD A SCALABLE, INTEGRATED, RAPID DESIGN AND PROTOTYPING INFRASTRUCTURE FOR THE FACILE ENGINEERING OF BIOLOGY. TECHICAL AREA (TA)1, THE SUBJECT OF THIS CONTRACT, TA2 WILL BUILD OFF OF AND EXECUTE THE IMPROVED TECHNICAL APPROACH AND PLAN GENERATED DURING TA1. TA2 WILL CONSIST OF THREE PHASES AND WILL REQUIRE THE PERFORMER TO DEMONSTRATE THEIR CAPABILITIES TO GENERATE GENETIC DESIGNS A

Who is the contractor on this award?

The obligated recipient is MASSACHUSETTS INSTITUTE OF TECHNOLOGY.

Which agency awarded this contract?

Awarding agency: Department of Defense (Defense Advanced Research Projects Agency).

What is the total obligated amount?

The obligated amount is $31.9 million.

What is the period of performance?

Start: 2015-05-04. End: 2022-03-31.

What is the specific track record of the Massachusetts Institute of Technology (MIT) in managing large-scale, multi-year federal R&D contracts, particularly in biotechnology?

MIT has a long and distinguished history of managing substantial federal research grants and contracts, particularly from agencies like DARPA, NSF, and NIH. Their extensive experience in biotechnology research is well-documented, with numerous high-impact publications and successful project completions. While specific details on the number and value of past DARPA contracts are not readily available in this context, MIT's consistent success in securing competitive research funding underscores its capability to manage complex, long-term R&D endeavors. Their robust infrastructure, experienced research personnel, and established administrative processes are well-suited for handling the demands of large-scale federal awards, including adherence to reporting requirements and milestone achievements.

How does the $31.8 million award compare to other DARPA investments in similar biotechnology research areas?

The $31.8 million award for DARPA's Living Foundries program is substantial, reflecting the ambitious and foundational nature of the research. DARPA typically invests in high-risk, high-reward projects that push the boundaries of science and technology. While specific funding levels for comparable biotechnology programs can fluctuate based on strategic priorities and technological advancements, this award is consistent with DARPA's historical investment patterns in areas like synthetic biology, advanced materials, and complex systems engineering. Such programs often require significant, multi-year funding to achieve breakthrough results, making this contract size appropriate for its intended scope and duration.

What are the primary technical risks associated with the Living Foundries program, and how are they being mitigated?

The primary technical risks associated with the Living Foundries program stem from the inherent complexity and novelty of engineering biological systems at scale. These include challenges in predicting the behavior of engineered molecules, ensuring the reliability and reproducibility of biological designs, and integrating diverse computational and experimental tools into a cohesive infrastructure. DARPA mitigates these risks through a phased approach, starting with an initial 'pressure test' requiring the production of 10 molecules. This allows for iterative development, testing, and refinement of the technical approach. Furthermore, the program's focus on building a scalable and rapid design infrastructure aims to address the fundamental challenges of complexity and predictability in synthetic biology.

What are the expected long-term impacts of the Living Foundries program on the field of biotechnology and related industries?

The Living Foundries program is expected to have a transformative long-term impact on the field of biotechnology. By developing a scalable, integrated, and rapid design and prototyping infrastructure for the engineering of biology, the program aims to significantly accelerate the pace of innovation. This could lead to breakthroughs in areas such as developing novel therapeutics, creating sustainable biofuels, engineering advanced biomaterials, and improving agricultural productivity. The ability to design and build biological systems with greater precision and speed could revolutionize drug discovery, personalized medicine, and industrial biotechnology, creating new economic opportunities and addressing critical societal challenges.

How has federal spending in biotechnology R&D, specifically by DARPA, evolved over the past decade?

Federal spending in biotechnology R&D, particularly by DARPA, has seen a significant increase and strategic shift over the past decade, driven by advancements in areas like genomics, synthetic biology, and artificial intelligence. DARPA has consistently prioritized programs that explore the frontiers of biological engineering, often with dual-use applications in defense and national security. Investments have moved towards more integrated approaches, focusing on designing and building complex biological systems rather than solely analyzing them. This evolution reflects a growing understanding of biology as an engineering discipline, with DARPA aiming to establish foundational capabilities that can be leveraged for a wide range of applications, from medical countermeasures to novel materials.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology

Product/Service Code: RESEARCH AND DEVELOPMENT › DEFENSE (OTHER) R&D

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: BASIC RESEARCH

Offers Received: 3

Pricing Type: COST NO FEE (S)

Evaluated Preference: NONE

Contractor Details

Address: 77 MASSACHUSETTS AVE, CAMBRIDGE, MA, 02139

Business Categories: Category Business, Corporate Entity Tax Exempt, Educational Institution, Higher Education, Nonprofit Organization, Not Designated a Small Business, Higher Education (Private), Higher Education (Public), Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $31,863,306

Exercised Options: $31,863,306

Current Obligation: $31,863,306

Subaward Activity

Number of Subawards: 32

Total Subaward Amount: $12,050,915

Contract Characteristics

Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED

Cost or Pricing Data: NOT OBTAINED - WAIVED

Timeline